- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Nobel Biocare Holding AG
Add to PortfolioNOBN:VX
10.300 CHF 0.300 3.00%As of 11:30:35 ET on 05/29/2012.
Snapshot for Nobel Biocare Holding AG (NOBN)
| Open: | 10.060 | Day's Range: | 10.040 - 10.380 | Volume: | 575,081 | Bid: | 10.300 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 10.000 | 52wk Range: | 7.657 - 18.501 | 1-Yr Rtn: | -43.83% | Ask: | 10.310 |
Key Statistics for NOBN
| Current P/E Ratio (ttm) | 26.7938 |
|---|---|
| Estimated P/E (12/2012) | 20.2710 |
| Earnings Per Share (EUR) (ttm) | 0.3200 |
| Est. EPS (EUR) (12/2012) | 0.4230 |
| Est. PEG Ratio | 0.8664 |
| Market Cap (M CHF) | 1,274.98 |
| Shares Outstanding (M) | 123.78 |
| Enterprise Value (M EUR) (ttm) | 1,070.95 |
| Enterprise Value/EBITDA (ttm) | 9.68 |
| Price/Book (mrq) | 3.7664 |
| Price/Sale (ttm) | 1.8367 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/10/2012 |
More NOBN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for NOBN
- Operating
- Investing
- Financing (M/EUR)
Company Profile & Key Executives for NOBN
Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.
| Richard T LaubeChief Executive Officer | Dirk W KirstenChief Financial Officer |
| Ernst ZaengerleExec VP:Global Operations | Hans GeiselhoringerExec VP:Global Marketing |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page